Status:
RECRUITING
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Northern Manhattan Perinatal Partnership
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Maternal Sepsis
Infections
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Sepsis is the second leading cause of maternal death in the U.S. Labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary study is to evaluate a ...
Detailed Description
Maternal sepsis is the second leading cause of maternal death, major cause of morbidity, and preventable in most cases. Labor, birth, and postpartum are periods of increased sepsis risk. While America...
Eligibility Criteria
Inclusion
- Birthing Person (EMR evaluation):
- Delivery hospitalizations and associated postpartum readmissions at the 4 hospital sites between 2020-2025
Exclusion
- Birthing Person (EMR evaluation)
- Delivery hospitalizations (and associated postpartum readmissions)to a hospital other than the 4 hospital sites or outside of 2020-2025 timeframe
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2026
Estimated Enrollment :
33183 Patients enrolled
Trial Details
Trial ID
NCT06145724
Start Date
June 1 2025
End Date
September 20 2026
Last Update
June 19 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia Unviersity Irving Medical Center
New York, New York, United States, 10032
2
NewYork-Presbyterian Allen Hospital
New York, New York, United States, 10034
3
NYC Health+Hospitals/Harlem
New York, New York, United States, 10037
4
NYC Health + Hospitals/Lincoln
The Bronx, New York, United States, 10451